Skip to content

Effect of High-intensity Laser Exercise Versus Moderate-intensity Aerobic Exercise on Diabetic Polyneuropathy Patients

Effect of High-intensity Laser Exercise Versus Moderate-intensity Aerobic Exercise on Diabetic Polyneuropathy Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06884462
Enrollment
60
Registered
2025-03-19
Start date
2024-11-01
Completion date
2025-03-01
Last updated
2025-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Nephropathies

Brief summary

Diabetic poly neuropathy (DPN) is a length-dependent, symmetrical sensorimotor poly neuropathy and is among the most prevalent and challenging consequences of diabetes4. The documented prevalence of DPN varies between 13% and 55%, with 25% to 50% of these individuals experiencing neuropathic pain5. This study was conducted to find out the impact of high-intensity laser versus moderate-intensity aerobic exercises on diabetic poly neuropathy patients.

Interventions

RADIATIONHigh-intensity laser (HIL)

The wavelength measured 1064 nm, accompanied by a power output of 5.00 W. The frequency employed was 25 Hz

walking on a treadmill at a speed of 3-4 miles per hour on a flat surface (0% incline) for 40 minutes, 3 times weekly over eight weeks

Sponsors

Deraya University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
MALE
Age
30 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Neuropathic symptoms in the lower limbs, including numbness, tingling, pain, burning, electric shock, and stabbing

Exclusion criteria

* sensory polyneuropathy unrelated to diabetes as * systemic diseases, * infections, * inflammatory conditions, * drug effects, * metal exposure, * hereditary factors

Design outcomes

Primary

MeasureTime frameDescription
Lower extremity functional performance3 monthsscale for both groups from 0 (minimum) to 80 (maximum)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026